CA1069052A - Composition containing bis-chromonyl compounds - Google Patents

Composition containing bis-chromonyl compounds

Info

Publication number
CA1069052A
CA1069052A CA257,889A CA257889A CA1069052A CA 1069052 A CA1069052 A CA 1069052A CA 257889 A CA257889 A CA 257889A CA 1069052 A CA1069052 A CA 1069052A
Authority
CA
Canada
Prior art keywords
composition
yloxy
bis
weight
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA257,889A
Other languages
English (en)
French (fr)
Inventor
John H. Bell
James E. Taylor
Clifford W.F. Clarke
Thomas J. Sullivan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of CA1069052A publication Critical patent/CA1069052A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA257,889A 1975-10-03 1976-07-27 Composition containing bis-chromonyl compounds Expired CA1069052A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40507/75A GB1537047A (en) 1975-10-03 1975-10-03 Eye ointment

Publications (1)

Publication Number Publication Date
CA1069052A true CA1069052A (en) 1980-01-01

Family

ID=10415247

Family Applications (1)

Application Number Title Priority Date Filing Date
CA257,889A Expired CA1069052A (en) 1975-10-03 1976-07-27 Composition containing bis-chromonyl compounds

Country Status (11)

Country Link
JP (1) JPS5244242A (nl)
BE (1) BE845709R (nl)
CA (1) CA1069052A (nl)
DK (1) DK355076A (nl)
FI (1) FI762625A (nl)
FR (1) FR2326189A2 (nl)
GB (1) GB1537047A (nl)
IT (1) IT1076941B (nl)
NL (1) NL7610057A (nl)
NO (1) NO762516L (nl)
SE (1) SE7608462L (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100592B1 (en) * 1982-07-02 1988-02-10 FISONS plc Eye ointments and a method for their production
GB8402574D0 (en) * 1984-02-01 1984-03-07 Fisons Plc Pharmaceutical formulation
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
GB9810949D0 (en) 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
JP3502574B2 (ja) * 1999-06-29 2004-03-02 東亜薬品株式会社 眼感染症治療用眼軟膏剤
WO2003013548A1 (fr) 2001-08-09 2003-02-20 Sekisui Chemical Co., Ltd. Composition medicale a usage externe destinee au traitement des dermatoses
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
JP7377562B2 (ja) * 2018-11-01 2023-11-10 イェディテペ・ウニヴェルシテシ 乾癬の治療のための医薬及びその製造方法

Also Published As

Publication number Publication date
FI762625A (nl) 1977-04-04
FR2326189B2 (nl) 1979-08-10
NL7610057A (nl) 1977-04-05
NO762516L (nl) 1977-04-05
DK355076A (da) 1977-04-04
FR2326189A2 (fr) 1977-04-29
JPS5244242A (en) 1977-04-07
BE845709R (fr) 1977-02-28
IT1076941B (it) 1985-04-27
GB1537047A (en) 1978-12-29
SE7608462L (sv) 1977-04-04

Similar Documents

Publication Publication Date Title
US4271182A (en) Method of treating atopic eczema
AU614712B2 (en) Pharmaceutical preparations containing formoterol or its salts, and a method of treating skin diseases
US4311707A (en) Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
DE69019297T2 (de) Verfahren zur Verwendung von (2-Imidazolin-2-ylamino)-Chinoxalinen zur Senkung oder Stabilisierung des intraokulären Druckes.
JP2683390B2 (ja) 局所適用のための医薬又は化粧品組成物
CA1069052A (en) Composition containing bis-chromonyl compounds
JPH0234948B2 (nl)
KR910000647A (ko) 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도
DD210908A5 (de) Verfahren zur herstellung von ketenthioacetaten
CA1085298A (en) Topical pharmaceutical composition
US3317382A (en) Substituted 5-phenylsalicylic acid compounds for the prevention and treatment of erythema
JPH0579058B2 (nl)
AU3096301A (en) Ophthalmic compositions for treating ocular hypertension
JP2003533463A (ja) チオエーテル、スルホキシド又はスルホン基を含む化合物の、汚染防止化粧剤としての使用
US4126695A (en) Anti-glaucoma composition and method
US3322635A (en) Cosmetic composition exhibiting pantothenic acid activity
EP0243905A1 (de) 1(omega-[bis-(Phenyl)-alkoxy]-alkyl)-4-(di-(phenyl)-methyl)- Piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE60112280T2 (de) Inhibitoren von peptid-deformylase
JP3033845B2 (ja) 皮膚炎を治療するための2,3−ジアリル−1−ベンゾピラン
JPS6058916A (ja) 抗真菌剤
KR940005621A (ko) 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도
DE3122791C2 (nl)
DE1795323A1 (de) Neue heterocyclische Verbindungen
JP3453152B2 (ja) 抗炎症点眼剤
EP0910374A1 (de) Topisch einsetzbare pharmazeutische formulierungen enthaltend als wirkstoff ein carbazolyl-(4)-oxy-propanolamin-derivat

Legal Events

Date Code Title Description
MKEX Expiry